IRIS
CHIARANTINI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.415
EU - Europa 6.420
AS - Asia 1.917
OC - Oceania 19
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 10
Totale 16.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.381
GB - Regno Unito 2.618
CN - Cina 1.433
IT - Italia 1.059
UA - Ucraina 1.053
SE - Svezia 606
FI - Finlandia 387
TR - Turchia 317
DE - Germania 289
IE - Irlanda 213
FR - Francia 73
IN - India 52
KR - Corea 42
RU - Federazione Russa 37
CA - Canada 31
BE - Belgio 24
AU - Australia 17
VN - Vietnam 17
ES - Italia 12
IR - Iran 12
PL - Polonia 12
EU - Europa 10
TG - Togo 8
SG - Singapore 7
NL - Olanda 6
AT - Austria 5
HK - Hong Kong 5
BR - Brasile 4
CH - Svizzera 4
JP - Giappone 4
BG - Bulgaria 3
CL - Cile 3
CZ - Repubblica Ceca 3
LA - Repubblica Popolare Democratica del Laos 3
MA - Marocco 3
PK - Pakistan 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
CI - Costa d'Avorio 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AR - Argentina 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
RS - Serbia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 16.807
Salva come PNG Salva come JPEG
Città #
Southend 2.440
Fairfield 1.049
Woodbridge 1.046
Jacksonville 860
Houston 846
Chandler 689
Ann Arbor 659
Ashburn 473
Cambridge 473
Nanjing 457
Seattle 440
Wilmington 396
Izmir 309
Urbino 216
Dublin 213
Nanchang 167
Helsinki 152
San Mateo 129
Princeton 125
New York 115
Shenyang 97
Beijing 92
Hebei 82
Jiaxing 79
Tianjin 77
Changsha 68
Düsseldorf 60
Mülheim 56
Jinan 55
Boardman 50
Kunming 50
San Diego 49
Bremen 42
Milan 32
San Francisco 32
Seongnam 30
Velikiy Novgorod 27
Brussels 23
London 23
Ningbo 23
Zhengzhou 21
Hangzhou 19
Toronto 18
Des Moines 17
Rome 16
Taizhou 16
Ancona 15
Guangzhou 15
Dong Ket 14
Lanzhou 13
Shanghai 12
Auburn Hills 10
Bologna 10
Fuzhou 9
Haikou 9
Melbourne 9
Mergo 9
Norwalk 9
Kraków 8
Lomé 8
Los Angeles 8
Redwood City 8
Turin 8
West Jordan 8
Changchun 7
Falls Church 7
Leawood 7
Orange 7
Osimo 7
Perugia 7
Portland 7
Avola 6
Gioia del Colle 6
Gunzenhausen 6
Ardabil 5
Augusta 5
Baranzate 5
Canberra 5
Frankfurt am Main 5
Mumbai 5
Ravenna 5
Venice 5
Acton 4
Civitanova Marche 4
Hamilton 4
Madrid 4
Monmouth Junction 4
Paris 4
Pesaro 4
San Colombano al Lambro 4
Washington 4
Alexandria 3
Bari 3
Centuripe 3
Chapel Hill 3
Edinburgh 3
Falkenstein 3
Hanover 3
Ho Chi Minh City 3
Hounslow 3
Totale 12.760
Salva come PNG Salva come JPEG
Nome #
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production 437
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 336
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 218
In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: analysis of a potential antilithiatic mechanism 210
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 203
Inhibition of macrophage iNOS by selective targeting of antisense PNA. 200
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 200
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 200
A versatile vector system for generating recombinant EGFP-tagged proteins in yeast 193
Chitosan Nanoparticles for Topical Co-Administration of the Antioxidants Glutathione and Idebenone: Characterization and In Vitro Release 193
Bacteria-produced ferric exopolysaccharide nanoparticles as iron delivery system for truffles (Tuber borchii) 192
Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency. 191
Erythrocyte-based drug delivery 190
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 190
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 189
Inhibition of murine AIDS by reduced glutathione. 185
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 183
Characterization and complementation of a Fus3/Kss1 type MAPK from Tuber borchii, TBMK 182
Drug delivery through phagocytosis of red blood cells 181
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 181
2',3'-Dideoxycytidine induced drug resistance in human cells 177
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 177
Comparison of novel delivery systems for antisense peptide nucleic acids 176
Simultaneous extraction and HPLC determination of ATP, ADP, AMP, NADP+ NADPH, NAD+ and NADH in human red blood cells. 168
Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine. 168
2',3'-Dideoxycytidine induced drug-resistance in human cells 166
Enhanced antisense effect of modified PNAs delivered through functional PMMA microspheres 164
Purification, properties, and evidence for two subtypes of human placenta hexokinase type I. 161
Red blood cells as a glucocorticoids delivery system 161
Immunological quantification of human hexokinase type I 160
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 158
Human erythrocyte hexokinases are immunologically related 157
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 156
Preparation and characterization of monoclonal antibodies to human hexokinase type I. 153
Red blood cells as glucocorticoids delivery system. 153
Dinuclear Copper (II) complex as nitric oxide scavenger in stimulated murine macrophage model 152
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 152
Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells 150
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 149
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 148
ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts. 147
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 146
Development of a multilevel approach for the evaluation of nanomaterials toxicity 146
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 145
Core-shell nanospheres for oligonucleotide delivery. V: adsorption/release behavior of 'stealth' nanospheres 143
The interaction of phosphorylated sugars with human hexokinase I. 143
Heat stress-activated, calcium dependent nitric oxide synthase in sponges 142
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 142
Glucose 1,6-diphosphate in the erythrocytes of various species of mammal 141
Targeting dexamethasone to macrophages. 140
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. 137
A Dinuclear Copper(II) Complex as Nitric Oxide Trapper in a Stimulated Murine Macrophage Model 137
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 137
Role of hexokinase in the regulation of glucose metabolism in human erythrocytes. 133
Immunological studies on mammalian hexokinase 133
Red blood cell phagocytosis following hexokinase inactivation. 133
Similarities and differences between human and rat hexokinases type I. 133
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 133
In vitro and in vivo toxicity of 2',3'-dideoxycytidine in mice 132
Red blood cells as carriers of drugs against retroviruses 132
Red blood cell mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. 131
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 131
CYTOTOXICITY AND PROINFLAMMATORY ACTIVITY OF DIESEL AND BIO-DIESEL EXHAUST PARTICLE ON HUMAN KERATINOCYTES. 130
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 130
Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter 128
CYTOTOXICITY OF NANOPARTICLES 128
Human erythrocytes phosphoglucomutase: comparison of the kinetic properties of PGM1 and PGM2 isoenzymes 127
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice 127
TOXICITY COMPARISON OF DIESEL EXHAUST PARTICLE (DEP) FROM AN URBAN BUS ENGINE FUELLED WITH DIESEL OIL AND 'BIODIESEL' BLEND. 126
Modulated red blood cell survival by membrane protein clustering 126
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens 125
Esocinasi in fibroblasti umani. 124
Red blood cells as an antigen-delivery system. 124
In vitro evaluation of nanomaterials toxicity 124
Introduction to in vivo targeting. 121
Use of fluorescent probes for describing the process of encapsulation by hypotonic dialysis. 120
Rabbit red blood cell hexokinase. Decay mechanism during reticulocyte maturation. 120
Vaccination strategy using red blood cells as antigen delivery system. 120
New drug combinations for the treatment of murine AIDS and macrophage protection. 120
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 119
Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells. 119
In vitro targeting of doxorubicin loaded canine erythrocytes to cytotoxic T-lymphocytes (CTLL). 118
A New Dinuclear Copper(II) Complex to Trap Nitric Oxide 116
Il glucoso 1,6 difosfato negli eritrociti di differenti specie di mammifero 115
Immobilization of enzymes and proteins on red blood cells. 114
Immobilization of enzymes and proteins on red blood cells. 111
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 109
Vie degradative del glucoso 1,6 difosfato negli eritrociti umani. 108
Role of macrophage protection in the development of murine AIDS. 107
New synthesis of a spin-labelled peptide nucleic acids and its interactions with nucleic acids 105
Studi preliminari sull’effetto proinfiammatorio in cheratinociti umani della porzione idrosolubile del particolato atmosferico frazionato. 102
NUCLEIC ACIDS AND PROTEIN DELIVERY THROUGH POLYMERIC CORE-SHELL NANOSPHERES 102
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 101
Effetto dell'età sulla sopravvivenza degli eritrociti di topo. 100
Role of macrophage protection in the development of murine AIDS 97
Decay mechanisms of rabbit hexokinase during reticulocyte maturation 96
Quantification of electrophoretic eluted protein. 96
Immunological studies on mammalian hexokinase. 95
Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate. 94
In vitro survival and in vitro phagocytosis of engineered erythrocytes. 92
Totale 14.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019951 0 0 0 0 0 0 0 0 0 0 280 671
2019/20203.791 809 149 257 898 154 272 333 272 173 217 87 170
2020/20212.050 65 159 129 243 121 175 99 163 319 170 294 113
2021/20221.277 80 120 157 191 40 46 56 73 82 65 23 344
2022/20232.475 235 104 40 225 194 456 7 152 537 137 277 111
2023/2024581 74 39 38 65 46 162 22 67 8 59 1 0
Totale 16.945